Manufacturing & Lab Equipment
Regulatory, Tech Transfer & Support Services
Company Overview
About
Wilco AG is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Switzerland
Founded:2017
Employees:1,594
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
Global
Regulatory Approvals
Drug Approval RPZYH2
FDA · #APR-TL50S0P3 · 2020-10-01
Drug Approval WYUJFY
Health Canada · #APR-GCUBTIAH · 2019-11-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-EMNW23O6
Issued: 2020-03-22
Expires: 2025-10-09
Health Canada GMP
Health Canada
Cert #: CERT-2TWUFUTU
Issued: 2020-03-12
Expires: 2025-09-05
Loading CDMO intelligence...
Key facts about Wilco AG
- Wilco AG is headquartered in Switzerland.
- Wilco AG was founded in 2017.
- Wilco AG has 1,594 employees.
- Wilco AG's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Wilco AG
Directory pages this company appears in, each with the full list of matching manufacturers.